SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-059364
Filing Date
2024-03-05
Accepted
2024-03-05 16:46:56
Documents
16
Period of Report
2024-03-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d747385d8k.htm   iXBRL 8-K 25433
2 EX-99.1 d747385dex991.htm EX-99.1 88230
6 GRAPHIC g747385g0305222241609.jpg GRAPHIC 3193
  Complete submission text file 0001193125-24-059364.txt   251341

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA iobt-20240305.xsd EX-101.SCH 2855
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE iobt-20240305_lab.xml EX-101.LAB 17909
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iobt-20240305_pre.xml EX-101.PRE 11237
17 EXTRACTED XBRL INSTANCE DOCUMENT d747385d8k_htm.xml XML 3616
Mailing Address OLE MAALOES VEH 3 COPENHAGEN G7 2200
Business Address OLE MAALOES VEH 3 COPENHAGEN G7 2200 4570702980
IO Biotech, Inc. (Filer) CIK: 0001865494 (see all company filings)

IRS No.: 870909276 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41008 | Film No.: 24721569
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)